1. |
Gertz MA. Waldenstrom macroglobulinemia: 2015 update on diagnosis, risk stratification, and management[J]. Am J Hematol, 2015, 90(4) : 346-354.
|
2. |
Dimopoulos MA, Gertz MA, Kastritis E, et al. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom’s macroglobulinemia[J]. J Clin Oncol, 2009, 27(1) : 120-126.
|
3. |
Iwanaga M, Yoshida Y, Tagawa M, et al. Waldenstrom’s macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance[J]. Leuk Res, 2009, 33(1) : 193-195.
|
4. |
Polprasert C, Wongchitrat C, Assanasen T, et al. Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement[J]. J Med Assoc Thai, 2009, 92(Suppl 3) : S65-S68.
|
5. |
Castillo JJ, Ghobrial IM, Treon SP.Biology, prognosis, and therapy of Waldenstrom macroglobulinemia[J]. Cancer Treat Res, 2015(165) : 177-195.
|
6. |
Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al. Waldenstrom’s macroglobulinemia: clinical features, complications, and management[J]. J Clin Oncol, 2000, 18(1) : 214-226.
|
7. |
Takahashi K, Yamamura F, Motoyama H. IgM myeloma--its distinction from Waldenstrom’s macroglobulinemia[J]. Acta Pathol Jpn, 1986, 36(10) : 1553-1563.
|
8. |
Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma[J]. Mayo Clin Proc, 2003, 78(1) : 21-33.
|
9. |
Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia[J]. Semin Oncol, 2003, 30(2) : 110-115.
|
10. |
Owen RG, Pratt G, Auer RL, et al. Guidelines on the diagnosis and management of Waldenstrom macroglobulinaemia[J]. Br J Haematol, 2014, 165(3) : 316-333.
|
11. |
Treon SP. How I treat Waldenström macroglobulinemia[J]. Blood, 2015, 126(6) : 721-732.
|
12. |
Zelenetz AD, Gordon LI, Wierda WG, et al. Non-Hodgkin’s lymphomas, version 4.2014[J]. J Natl Compr Canc Netw, 2014, 12(9) : 1282-1303.
|
13. |
Reddy KR, Beavers KL, Hammond SP,et al. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy[J]. Gastroenterology, 2015, 148(1) : 215-219.
|
14. |
Izzedine H, Bourry E, Amrouche L, et al. Immunoglobulin M “Flare” after rituximab-associated acute tubular necrosis in Waldenström’s macroglobulinemia[J]. Int J Hematol, 2009, 89(2) : 218-222.
|
15. |
Noronha V, Fynan TM, Duffy T. Flare in neuropathy following rituximab therapy for Waldenstrom’s macroglobulinemia[J]. J Clin Oncol, 2006, 24(1) : e3.
|
16. |
于亚平, 翟勇平, 史平, 等. 利妥昔单抗治疗华氏巨球蛋白血症时的特殊反应[J]. 现代肿瘤医学, 2011, 19(6) : 1202-1206.
|